Persistence of Cognitive Impairment After Resolution of Overt Hepatic Encephalopathy

Gastroenterology

Volumn 138, Issue 7, 2010, Pages 2332-2340

  Bajaj, Jasmohan S ^a,b   Schubert, Christine M ^a   Heuman, Douglas M ^a   Wade, James B ^a   Gibson, Douglas P ^a   Topaz, Allyne ^a   Saeian, Kia ^b   Hafeezullah, Muhammad ^b   Bell, Debulon E ^a   Sterling, Richard K ^a   Stravitz, R Todd ^a   Luketic, Velimir ^a   White, Melanie B ^a   Sanyal, Arun J ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Cirrhosis; Cognition; Complications; Portal Hypertension

Indexed keywords

LACTULOSE; RIFAXIMIN;

ADULT; ARTICLE; BRAIN FUNCTION; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE CONTROL; DISEASE SEVERITY; FUNCTIONAL ASSESSMENT; HEPATIC ENCEPHALOPATHY; HUMAN; LEARNING DISORDER; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MEMORY DISORDER; MENTAL PERFORMANCE; MINIMAL RESIDUAL DISEASE; PATIENT COMPLIANCE; PRIORITY JOURNAL; WORKING MEMORY;

EID: 77952744973     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2010.02.015     Document Type: Article

References (34)

1. Bajaj J.S., Wade J.B., and Sanyal A.J. Spectrum of neurocognitive impairment in cirrhosis: implications for the assessment of hepatic encephalopathy. Hepatology 50 (2009) 2014-2021
2. Ortiz M., Jacas C., and Cordoba J. Minimal hepatic encephalopathy: diagnosis, clinical significance and recommendations. J Hepatol 42 Suppl (2005) S45-S53
3. Prasad S., Dhiman R.K., Duseja A., et al. Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy. Hepatology 45 (2007) 549-559
4. Sotil E.U., Gottstein J., Ayala E., et al. Impact of preoperative overt hepatic encephalopathy on neurocognitive function after liver transplantation. Liver Transpl 15 (2009) 184-192
5. Butterworth R.F., Giguere J.F., Michaud J., et al. Ammonia: key factor in the pathogenesis of hepatic encephalopathy. Neurochem Pathol 6 (1987) 1-12
6. Rose C., and Jalan R. Is minimal hepatic encephalopathy completely reversible following liver transplantation?. Liver Transpl 10 (2004) 84-87
7. Butterworth R.F. Neuronal cell death in hepatic encephalopathy. Metab Brain Dis 22 (2007) 309-320
8. Stewart C.A., Malinchoc M., Kim W.R., et al. Hepatic encephalopathy as a predictor of survival in patients with end-stage liver disease. Liver Transpl 13 (2007) 1366-1371
9. Ferenci P., Lockwood A., Mullen K., et al. Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 35 (2002) 716-721
10. Weissenborn K., Ennen J.C., Schomerus H., et al. Neuropsychological characterization of hepatic encephalopathy. J Hepatol 34 (2001) 768-773
11. Bajaj J.S., Hafeezullah M., Franco J., et al. Inhibitory control test for the diagnosis of minimal hepatic encephalopathy. Gastroenterology 135 (2008) 1591-1600
12. Garavan H., Ross T.J., and Stein E.A. Right hemispheric dominance of inhibitory control: an event-related functional MRI study. Proc Natl Acad Sci U S A 96 (1999) 8301-8306
13. Bajaj J.S., Saeian K., Schubert C.M., et al. Minimal hepatic encephalopathy is associated with motor vehicle crashes: the reality beyond the driving test. Hepatology 50 (2009) 1175-1183
14. Folstein M.F., Folstein S.E., and McHugh P.R. "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12 (1975) 189-198
15. Garcia-Tsao G., and Lim J.K. Management and treatment of patients with cirrhosis and portal hypertension: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program. Am J Gastroenterol 104 (2009) 1802-1829
16. Bergeron M., Reader T.A., Layrargues G.P., et al. Monoamines and metabolites in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. Neurochem Res 14 (1989) 853-859
17. de Waele J.P., Audet R.M., Leong D.K., et al. Portacaval anastomosis induces region-selective alterations of the endogenous opioid system in the rat brain. Hepatology 24 (1996) 895-901
18. Pomier-Layrargues G., Spahr L., and Butterworth R.F. Increased manganese concentrations in pallidum of cirrhotic patients. Lancet 345 (1995) 735
19. Zieve L., Doizaki W.M., and Zieve J. Synergism between mercaptans and ammonia or fatty acids in the production of coma: a possible role for mercaptans in the pathogenesis of hepatic coma. J Lab Clin Med 83 (1974) 16-28
20. Kril J.J., and Butterworth R.F. Diencephalic and cerebellar pathology in alcoholic and nonalcoholic patients with end-stage liver disease. Hepatology 26 (1997) 837-841
21. Krieger S., Jauss M., Jansen O., et al. Neuropsychiatric profile and hyperintense globus pallidus on T1-weighted magnetic resonance images in liver cirrhosis. Gastroenterology 111 (1996) 147-155
22. Mullen K.D., Cole M., and Foley J.M. Neurological deficits in "awake" cirrhotic patients on hepatic encephalopathy treatment: missed metabolic or mental disorder?. Gastroenterology 111 (1996) 256-257
23. Gropman A.L., and Batshaw M.L. Cognitive outcome in urea cycle disorders. Mol Genet Metab 81 Suppl 1 (2004) S58-S62
24. Giguere J.F., and Butterworth R.F. Amino acid changes in regions of the CNS in relation to function in experimental portal-systemic encephalopathy. Neurochem Res 9 (1984) 1309-1321
25. Derbyshire S.W., Vogt B.A., and Jones A.K. Pain and Stroop interference tasks activate separate processing modules in anterior cingulate cortex. Exp Brain Res 118 (1998) 52-60
26. Passingham R.E. Attention to action. Philos Trans R Soc Lond B Biol Sci 351 (1996) 1473-1479
27. Cohen J.D., Perlstein W.M., Braver T.S., et al. Temporal dynamics of brain activation during a working memory task. Nature 386 (1997) 604-608
28. Friedman N.P., Miyake A., Corley R.P., et al. Not all executive functions are related to intelligence. Psychol Sci 17 (2006) 172-179
29. Zafiris O., Kircheis G., Rood H.A., et al. Neural mechanism underlying impaired visual judgement in the dysmetabolic brain: an fMRI study. Neuroimage 22 (2004) 541-552
30. Zhang L.J., Yang G., Yin J., et al. Neural mechanism of cognitive control impairment in patients with hepatic cirrhosis: a functional magnetic resonance imaging study. Acta Radiol 48 (2007) 577-587
31. Shawcross D.L., Wright G., Olde Damink S.W., et al. Role of ammonia and inflammation in minimal hepatic encephalopathy. Metab Brain Dis 22 (2007) 125-138
32. Fan P., Lavoie J., Le N.L., et al. Neurochemical and electrophysiological studies on the inhibitory effect of ammonium ions on synaptic transmission in slices of rat hippocampus: evidence for a postsynaptic action. Neuroscience 37 (1990) 327-334
33. Ahboucha S., Layrargues G.P., Mamer O., et al. Increased brain concentrations of a neuroinhibitory steroid in human hepatic encephalopathy. Ann Neurol 58 (2005) 169-170
34. Butterworth R.F., Le O., Lavoie J., et al. Effect of portacaval anastomosis on electrically stimulated release of glutamate from rat hippocampal slices. J Neurochem 56 (1991) 1481-1484